MedTrace Logo

Quality of Life After Transanal Total Mesorectal Excision Compared to Traditional Total Mesorectal Excision

NCT06505863 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 249

Last updated 2025-07-14

No results posted yet for this study

Summary

The improvement in prognosis of rectal cancer through modern therapy modalities rises questions regarding quality of life (QoL) and functional outcomes. Evidence for long-term QoL and functional outcomes of transanal total mesorectal excision (taTME) is not provided in current literature. This study will compare short-term and long-term QoL and functional outcomes after taTME compared to traditional abdominal TME (laparoscopic, robotic, and open approach)

Conditions

Interventions

PROCEDURE

Transanal total mesorectal excision

Transanal approach in surgical treatment of rectal cancer along the anatomical and embryological planes, called total mesorectal excision, as described in 1988 by Heald et al.

PROCEDURE

Abdominal total mesorectal excision

Patients who underwent laparoscopic, robotic, or open total mesorectal excision with anastomosis for primary rectal cancer UICC stage I to III

Sponsors & Collaborators

  • Cantonal Hospital of St. Gallen

    lead OTHER

Principal Investigators

  • Walter Brunner, PD Dr. med. · Cantonal Hospital of St. Gallen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-01
Primary Completion
2025-01-01
Completion
2025-07-01

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06505863 on ClinicalTrials.gov